Latest filing published 03 Feb 2026 for Atea Pharmaceuticals, Inc., €43k.
Wayne Foster discloses dealings in 2 companies, chiefly Atea Pharmaceuticals, Inc. and Mersana Therapeutics, Inc. Between 30 January 2018 and 31 January 2026, the trades on record add up to 11 filings.
The open-market record consists of 1 sale worth €44k, with no purchase. Other entries cover 3 share grants and 7 option exercises.
The record was last updated on 3 February 2026 with a share grant (€43k) in Atea Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations